Loading clinical trials...
Loading clinical trials...
A 12-Week, Phase 2, Multicenter, Randomized, Double-Masked, Vehicle Controlled, Parallel Group Study With 2 Weeks of Follow-Up to Evaluate the Efficacy and Safety of DFL24498 0.08% Topical Ophthalmic Solution Versus Vehicle in Participants With Dry Eye Disease
Conditions
Interventions
DFL24498
Vehicle
Start Date
May 1, 2026
Primary Completion Date
January 24, 2027
Completion Date
February 7, 2027
Last Updated
March 31, 2026
NCT07463950
NCT07396441
NCT06841471
NCT07268599
NCT06981104
NCT07068958
Lead Sponsor
Dompé Farmaceutici S.p.A
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions